Bellevue Healthcare Trust PLC

Net Asset Value • Jun 20, 2023

National Storage Mechanism | Additional information /*<![CDATA[*/ /**/ /**/ /**/ .k{size:595.3pt 841.9pt;margin:72.0pt 72.0pt 72.0pt 72.0pt;}div.k{}p.t{margin:0cm;margin-bottom:.0001pt;font-size:12.0pt;font-family:"Times New Roman","serif";text-align:justify}span.r{font-family:"Calibri","sans-serif";color:black}span.u{font-family: "Calibri","sans-serif"; font-weight: bold}span.v{font-family:"Calibri","sans-serif"}p.a,li.a,div.a{margin:0cm;margin-bottom:.0001pt;font-size:12.0pt;font-family:"Times New Roman","serif";}p.d{margin:0cm;margin-bottom:.0001pt;font-size:10.0pt;font-family:"Courier New";}span.w{font-size:12.0pt; font-family:"Calibri","sans-serif"}span.x{font-size:12.0pt;font-family: "Calibri","sans-serif"} span.l{font-family:"Arial","sans-serif"} .fr-view-element{font-family: sans-serif;font-size: 12pt;line-height: 140%;padding: 20px;box-sizing: border-box;overflow-x: auto;min-height: 60px;text-align: left;margin-bottom: 10px;width: 837px;} .fr-view-element img{padding: 0 1px;} .fr-view-element .k{margin: 63.8pt 1.6cm 62.35pt 1.6cm;} .fr-view-element p{font-size: 10pt;} /**/ /**/ /**/ /*]]>*/

RNS Number : 2974D

Bellevue Healthcare Trust PLC

20 June 2023

Bellevue Healthcare Trust plc

Compliance with Market Abuse Regulation

Bellevue Healthcare Trust plc (the "Company") announces that it is satisfied that all inside information which the Directors and the Company may have to the date of this announcement has previously been notified to a regulatory information service.

The Company is therefore not prohibited from repurchasing its own securities, or issuing new securities, during the closed period which ends on the date of the announcement of the Half Yearly Financial Report for the six months ended 31 May 2023.

The Company's LEI is: 5213800HQ3J3H9YF2UI8

Enquiries:

Company Secretary                020 3327 9720

Apex Listed Companies Services (UK) Limited

20 June 2023

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

CMCPPUAUQUPWUBU